Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial

M.M. Nijkamp, P.N. Span, C.H.J. Terhaard, P.A.H. Doornaert, J.A. Langendijk, P.L.A. van den Ende, M. de Jong, A.J. van der Kogel, J. Bussink, J.H.A.M. Kaanders

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)3202-3209
JournalEuropean Journal of Cancer
Volume49
Issue number15
DOIs
Publication statusPublished - 2013

Cite this

Nijkamp, M. M., Span, P. N., Terhaard, C. H. J., Doornaert, P. A. H., Langendijk, J. A., van den Ende, P. L. A., ... Kaanders, J. H. A. M. (2013). Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial. European Journal of Cancer, 49(15), 3202-3209. https://doi.org/10.1016/j.ejca.2013.06.024